Mar 14, 2017 20:06 pm UTC| Business
STEVENSON, Md., March 14, 2017 -- The securities litigation law firm of Brower Piven, A Professional Corporation, announces that a class action lawsuit has been commenced in the United States District Court for the...
FTD Companies, Inc. Announces Fourth Quarter and Full Year 2016 Financial Results
Mar 14, 2017 20:06 pm UTC| Business
DOWNERS GROVE, Ill., March 14, 2017 -- FTD Companies, Inc. (Nasdaq:FTD) (“FTD” or the “Company”), a premier floral and gifting company, today announced financial results for the fourth quarter and full year ended...
FTD Companies, Inc. Announces Fourth Quarter and Full Year 2016 Financial Results
Mar 14, 2017 20:06 pm UTC| Business
DOWNERS GROVE, Ill., March 14, 2017 -- FTD Companies, Inc. (Nasdaq:FTD) (“FTD” or the “Company”), a premier floral and gifting company, today announced financial results for the fourth quarter and full year ended...
ChemoCentryx Reports Fourth Quarter and Full Year 2016 Financial Results
Mar 14, 2017 20:06 pm UTC| Business
-- Expanded Vifor Pharma partnership now totals $155 million in upfront cash commitments, $1.2 billion in potential milestone payments, plus substantial royalties on potential net sales -- -- Initiated Phase III clinical...
ChemoCentryx Reports Fourth Quarter and Full Year 2016 Financial Results
Mar 14, 2017 20:06 pm UTC| Business
-- Expanded Vifor Pharma partnership now totals $155 million in upfront cash commitments, $1.2 billion in potential milestone payments, plus substantial royalties on potential net sales -- -- Initiated Phase III clinical...
Connecture Reports Financial Results for Fourth Quarter and Full Year 2016
Mar 14, 2017 20:05 pm UTC| Business
Completes Additional Investment led by Francisco PartnersContracted Backlog Grows on Fourth Quarter Sales Activity BROOKFIELD, Wis., March 14, 2017 -- Connecture, Inc.(Nasdaq:CNXR), a provider of web-based information...
Mar 14, 2017 20:05 pm UTC| Business
SAN DIEGO, March 14, 2017 -- TRACON Pharmaceuticals (NASDAQ:TCON), a clinical stage biopharmaceutical company focused on the development and commercialization of novel targeted therapeutics for cancer, wet age‐related...